Global Health Progress

Discover why Global Health Progress supports drug development to combat “untouchable” diseases.

The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) and the Global Health Progress (GHP) initiative are organizing a “Geneva Health Roundtable” at the World Meteorological Organization in Geneva on Friday 24 September 2010, to highlight the challenges related to pediatric AIDS, and what is being done to address them.

Learn why Global Health Progress supports the decision by Medicines for Malaria Venture to join The Pool for Open Innovation against Neglected Tropical Diseases.

“We can no longer differentiate between diseases of the poor and the rich.”

That’s the conclusion of a newly published health policy paper whose authors include Sanjay Gupta, Lance Armstrong, economist Jeffrey Sachs and global-health pioneer Paul Farmer as well as the head of the American Cancer Society and other public-health biggies. All are members of the Global Task Force on Expanded Access to Cancer Care and Control in Developing Countries.

Read how Global Health Progress stresses importance of product development partnerships in light of recent Forbes commentary that questions PDP’s role in fighting neglected diseases.

Read how the recent “African Leaders Malaria Alliance” meeting highlighted partnerships, such as ones with the pharmaceutical industry, as key in moving forward with development of a malaria vaccine.

Global Health Progress epitomizes Clinton, Gates’ call for “efficiency savings” in regards to HIV/AIDs prevention and services by highlighting the importance of collaborative partnerships and securing resources, such as access to drugs

This week Uganda is hosting the AU Heads of State Summit, with a focus on “Maternal, Infant and Child Health and Development in Africa.”